Potential role of the formation of tunneling nanotubes in HIV-1 spread in macrophages

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1832-1841

  Hashimoto, Michihiro ^a   Bhuyan, Farzana ^a   Hiyoshi, Masateru ^a,d   Noyori, Osamu ^a   Nasser, Hesham ^a   Miyazaki, Mitsue ^a   Saito, Tamio ^b   Kondoh, Yasumitsu ^b   Osada, Hiroyuki ^b   Kimura, Shunsuke ^c,e   Hase, Koji ^c,f   Ohno, Hiroshi ^c   Suzu, Shinya ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Elements Chemistry Laboratory   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e HOKKAIDO UNIVERSITY   (Japan)

^f KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NEF PROTEIN; PROTEIN M SEC; UNCLASSIFIED DRUG; CYTOKINE; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; TNFAIP2 PROTEIN, HUMAN;

ARTICLE; BLOOD; CELL COUNT; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; ECTOPIC EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; MONOCYTE DERIVED MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TUNNELING NANOTUBE; VIRUS MUTANT; VIRUS REPLICATION; CELL COMMUNICATION; CELL LINE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; METABOLISM; PATHOGENICITY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL COMMUNICATION; CELL LINE; CYTOKINES; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HIV-1; HUMANS; MACROPHAGES; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84958559716     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500845     Document Type: Article

References (49)

1. Rustom, A., R. Saffrich, I. Markovic, P. Walther, and H. H. Gerdes. 2004. Nanotubular highways for intercellular organelle transport. Science 303: 1007-1010.
2. Onfelt, B., S. Nedvetzki, K. Yanagi, and D. M. Davis. 2004. Cutting edge: membrane nanotubes connect immune cells. J. Immunol. 173: 1511-1513.
3. Watkins, S. C., and R. D. Salter. 2005. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 23: 309-318.
4. Onfelt, B., S. Nedvetzki, R. K. Benninger, M. A. Purbhoo, S. Sowinski, A. N. Hume, M. C. Seabra, M. A. Neil, P. M. French, and D. M. Davis. 2006. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J. Immunol. 177: 8476-8483.
5. Chinnery, H. R., E. Pearlman, and P. G. McMenamin. 2008. Cutting edge: membrane nanotubes in vivo: A feature of MHC class II+ cells in the mouse cornea. J. Immunol. 180: 5779-5783.
6. Chauveau, A., A. Aucher, P. Eissmann, E. Vivier, and D. M. Davis. 2010. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proc. Natl. Acad. Sci. USA 107: 5545-5550.
7. Pyrgaki, C., P. Trainor, A. K. Hadjantonakis, and L. Niswander. 2010. Dynamic imaging of mammalian neural tube closure. Dev. Biol. 344: 941-947.
8. Davis, D. M., and S. Sowinski. 2008. Membrane nanotubes: dynamic longdistance connections between animal cells. Nat. Rev. Mol. Cell Biol. 9: 431-436.
9. Gerdes, H. H., and R. N. Carvalho. 2008. Intercellular transfer mediated by tunneling nanotubes. Curr. Opin. Cell Biol. 20: 470-475.
10. Wang, X., M. L. Veruki, N. V. Bukoreshtliev, E. Hartveit, and H. H. Gerdes. 2010. Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels. Proc. Natl. Acad. Sci. USA 107: 17194-17199.
11. Costanzo, M., S. Abounit, L. Marzo, A. Danckaert, Z. Chamoun, P. Roux, and C. Zurzolo. 2013. Transfer of polyglutamine aggregates in neuronal cells occurs in tunneling nanotubes. J. Cell Sci. 126: 3678-3685.
12. Rainy, N., D. Chetrit, V. Rouger, H. Vernitsky, O. Rechavi, D. Marguet, I. Goldstein, M. Ehrlich, and Y. Kloog. 2013. H-Ras transfers from B to T cells via tunneling nanotubes. Cell Death Dis. 4: e726.
13. Wang, X., and H. H. Gerdes. 2015. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 22: 1181-1191 .
14. Gousset, K., E. Schiff, C. Langevin, Z. Marijanovic, A. Caputo, D. T. Browman, N. Chenouard, F. de Chaumont, A. Martino, J. Enninga, et al. 2009. Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 11: 328-336.
15. Van Prooyen, N., H. Gold, V. Andresen, O. Schwartz, K. Jones, F. Ruscetti, S. Lockett, P. Gudla, D. Venzon, and G. Franchini. 2010. Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc. Natl. Acad. Sci. USA 107: 20738-20743.
16. Sowinski, S., C. Jolly, O. Berninghausen, M. A. Purbhoo, A. Chauveau, K. Köhler, S. Oddos, P. Eissmann, F. M. Brodsky, C. Hopkins, et al. 2008. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 10: 211-219.
17. Kadiu, I., M. Ricardo-Dukelow, P. Ciborowski, and H. E. Gendelman. 2007. Cytoskeletal protein transformation in HIV-1-infected macrophage giant cells. J. Immunol. 178: 6404-6415.
18. Kadiu, I., and H. E. Gendelman. 2011. Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infection. J. Neuroimmune Pharmacol. 6: 658-675.
19. Kadiu, I., and H. E. Gendelman. 2011. Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and Golgi network. J. Proteome Res. 10: 3225-3238.
20. Eugenin, E. A., P. J. Gaskill, and J. W. Berman. 2009. Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: A potential mechanism for intercellular HIV trafficking. Cell. Immunol. 254: 142-148.
21. Zaccard, C. R., S. C. Watkins, P. Kalinski, R. J. Fecek, A. L. Yates, R. D. Salter, V. Ayyavoo, C. R. Rinaldo, and R. B. Mailliard. 2015. CD40L induces functional tunneling nanotube networks exclusively in dendritic cells programmed by mediators of type 1 immunity. J. Immunol. 194: 1047-1056.
22. Xu, W., P. A. Santini, J. S. Sullivan, B. He, M. Shan, S. C. Ball, W. B. Dyer, T. J. Ketas, A. Chadburn, L. Cohen-Gould, et al. 2009. HIV-1 evades virusspecific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 10: 1008-1017.
23. Moir, S., and A. S. Fauci. 2010. Nef, macrophages and B cells: A highway for evasion. Immunol. Cell Biol. 88: 1-2.
24. Malbec, M., F. Roesch, and O. Schwartz. 2011. A new role for the HTLV-1 p8 protein: increasing intercellular conduits and viral cell-to-cell transmission. Viruses 3: 254-259.
25. Chihara, T., M. Hashimoto, A. Osman, Y. Hiyoshi-Yoshidomi, I. Suzu, N. Chutiwitoonchai, M. Hiyoshi, S. Okada, and S. Suzu. 2012. HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. J. Immunol. 188: 3620-3627.
26. Osman, A., F. Bhuyan, M. Hashimoto, H. Nasser, T. Maekawa, and S. Suzu. 2014. M-CSF inhibits anti-HIV-1 activity of IL-32, but they enhance M2-like phenotypes of macrophages. J. Immunol. 192: 5083-5089.
27. Tee, K. K., S. Kusagawa, X. J. Li, N. Onogi, M. Isogai, S. Hase, R. Uenishi, H. Liao, A. Kamarulzaman, and Y. Takebe. 2009. Isolation and characterization of a replication-competent molecular clone of an HIV-1 circulating recombinant form (CRF33-01B). PLoS One 4: e6666.
28. Hagiwara, K., T. Murakami, G. Xue, Y. Shimizu, E. Takeda, Y. Hashimoto, K. Honda, Y. Kondoh, H. Osada, Y. Tsunetsugu-Yokota, and Y. Aida. 2010. Identification of a novel Vpr-binding compound that inhibits HIV-1 multiplication in macrophages by chemical array. Biochem. Biophys. Res. Commun. 403: 40-45.
29. Nakajima, Y., T. Kawamura, K. Maeda, H. Ichikawa, T. Motoyama, Y. Kondoh, T. Saito, T. Kobayashi, M. Yoshida, H. Osada, and M. Kimura. 2013. Identification and characterization of an inhibitor of trichothecene 3-O-acetyltransferase, TRI101, by the chemical array approach. Biosci. Biotechnol. Biochem. 77: 1958-1960.
30. Chutiwitoonchai, N., M. Hiyoshi, P. Mwimanzi, T. Ueno, A. Adachi, H. Ode, H. Sato, O. T. Fackler, S. Okada, and S. Suzu. 2011. The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement. PLoS One 6: e27696.
31. Hiyoshi, M., S. Suzu, Y. Yoshidomi, R. Hassan, H. Harada, N. Sakashita, H. Akari, K. Motoyoshi, and S. Okada. 2008. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Blood 111: 243-250.
32. Hase, K., S. Kimura, H. Takatsu, M. Ohmae, S. Kawano, H. Kitamura, M. Ito, H. Watarai, C. C. Hazelett, C. Yeaman, and H. Ohno. 2009. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex. Nat. Cell Biol. 11: 1427-1432.
33. Kimura, S., K. Hase, and H. Ohno. 2013. The molecular basis of induction and formation of tunneling nanotubes. Cell Tissue Res. 352: 67-76.
34. Gousset, K., L. Marzo, P. H. Commere, and C. Zurzolo. 2013. Myo10 is a key regulator of TNT formation in neuronal cells. J. Cell Sci. 126: 4424-4435.
35. Yonezawa, S., A. Kimura, S. Koshiba, S. Masaki, T. Ono, A. Hanai, S. Sonta, T. Kageyama, T. Takahashi, and A. Moriyama. 2000. Mouse myosin X: molecular architecture and tissue expression as revealed by northern blot and in situ hybridization analyses. Biochem. Biophys. Res. Commun. 271: 526-533.
36. He, B., and W. Guo. 2009. The exocyst complex in polarized exocytosis. Curr. Opin. Cell Biol. 21: 537-542.
37. Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229: 563-566.
38. Ruckes, T., D. Saul, J. Van Snick, O. Hermine, and R. Grassmann. 2001. Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309. Blood 98: 1150-1159.
39. Dimitrov, D. S., R. L. Willey, H. Sato, L. J. Chang, R. Blumenthal, and M. A. Martin. 1993. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67: 2182-2190.
40. Sourisseau, M., N. Sol-Foulon, F. Porrot, F. Blanchet, and O. Schwartz. 2007. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J. Virol. 81: 1000-1012.
41. Foster, J. L., and J. V. Garcia. 2008. HIV-1 Nef: at the crossroads. Retrovirology 5: 84.
42. Abraham, L., and O. T. Fackler. 2012. HIV-1 Nef: A multifaceted modulator of T cell receptor signaling. Cell Commun. Signal. 10: 39.
43. Mukerji, J., K. C. Olivieri, V. Misra, K. A. Agopian, and D. Gabuzda. 2012. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology 9: 33.
44. Schiller, C., K. N. Diakopoulos, I. Rohwedder, E. Kremmer, C. von Toerne, M. Ueffing, U. H. Weidle, H. Ohno, and E. H. Weiss. 2013. LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation. J. Cell Sci. 126: 767-777.
45. Saksela, K., G. Cheng, and D. Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14: 484-491.
46. Kestler, H. W., III, D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651-662.
47. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332: 228-232.
48. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270: 988-991.
49. Sherer, N. M., M. J. Lehmann, L. F. Jimenez-Soto, C. Horensavitz, M. Pypaert, and W. Mothes. 2007. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat. Cell Biol. 9: 310-315.